ReCode LAB

We focus on reprogramming the immune microenvironment to address intractable diseases.

Our goal is to overcome therapeutic resistance and restore immune balance through innovative and multidisciplinary approaches.

To achieve this, we develop advanced delivery platforms
[extracellular vesicles (EVs), antibody/peptide-drug conjugates (ADCs, PDCs), and lipid nanoparticles (LNPs)]

that enable the precise and efficient delivery of small molecules and nucleic acids to target cells and tissues.
We also harness molecular tools like PROTACs, miRNAs, siRNAs, and mRNAs
to fine-tune gene expression and protein activity.

By integrating these technologies, we develop targeted therapies for hard-to-treat diseases
by reprogramming cellular functions and immune responses.